SCHEMBL6155481

SCHEMBL6155481

Oc1c[c]cc(Oc2cccc(C(F)(F)F)c2)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TEAD1 P28347 1/20 0.43
RAB9A P51151 1/20 0.43
MAOB P27338 1/20 0.42
AOC3 Q16853 1/20 0.42
LTA4H P09960 1/20 0.41
MAPT P10636 1/20 0.41
KIF11 P52732 1/20 0.41
POLB P06746 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
MRGPRX4 Q96LA9 1/20 0.40
ALDH1A1 P00352 1/20 0.40
KDM4E B2RXH2 1/20 0.40
TLR8 Q9NR97 1/20 0.39
TLR7 Q9NYK1 1/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
PPARG P37231 1/20 0.39
RECQL P46063 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6154229 0.89 TEAD1 (0.48) TEAD1MAOBAOC3LTA4HMAPT
SCHEMBL6229502 0.84 RAB9A (0.56) TEAD1RAB9AMAOBAOC3LTA4H
SCHEMBL9589388 0.82 RAB9A (0.55) TEAD1RAB9AMAOBAOC3LTA4H
SCHEMBL9589666 0.81 RAB9A (0.54) TEAD1RAB9ALTA4HMAPTKIF11
SCHEMBL9798371 0.80 LTA4H (0.54) TEAD1MAOBAOC3LTA4HMAPT
SCHEMBL919095 0.80 TEAD1 (0.46) TEAD1LTA4HMAPTKIF11POLB
SCHEMBL4043144 0.79 LTA4H (0.53) TEAD1LTA4HMAPTKIF11MRGPRX4
SCHEMBL9589615 0.79 LTA4H (0.53) TEAD1LTA4HMAPTKIF11MRGPRX4
SCHEMBL9589071 0.78 LTA4H (0.52) TEAD1LTA4HMAPTKIF11ALDH1A1
SCHEMBL27579381 0.76 LTA4H (0.59) TEAD1LTA4HMAPTKIF11POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US disclosed
EP-1446110-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES Structural Bioinformatics Inc. (US) 2004-08-18 EP disclosed
WO-2003032916-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES STRUCTURAL BIOINFORMATICS INC. (US) 2003-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases PTPRS, PTPRJ, PTPRCAP TEAD1 1649/4885RAB9A 3814/4885MAOB 3660/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.